FIGURE 1.

The estimated boundary values (the maximum of Youden index) for waist-to-height ratio in each race/ethnic group to screen for subclinical inflammation, hypertension, dyslipidemia, prediabetes/diabetes, or any (≥1) of these cardiometabolic outcomes. The bar graphs present the frequencies of waist-to-height ratios in each race/ethnic group. The dashed line denotes the waist-to-height ratio boundary value of 0.50. Subclinical inflammation was defined as high-sensitivity C-reactive protein ≥2 mg/L (Blaha et al., 2011). Hypertension was defined as blood pressure ≥140/90 mm Hg, or use of prescription antihypertensive medications (Go et al., 2014). Dyslipidemia was defined as fasting triglyceride level ≥1.70 mmol/L (or non-fasting ≥2.26 mmol/L – less than 5% of samples were non-fasting), or HDL-cholesterol <1.29 mmol/L or use of any prescription lipid-lowering medications (Stone et al., 2014). Prediabetes/diabetes was defined as fasting blood glucose ≥5.56 mmol/L (or non-fasting ≥7.78 mmol/L), self-reported diagnosis of diabetes, or use of glucose-lowering medications (American Diabetes Association, 2015)